Clinical Trials Directory

Trials / Completed

CompletedNCT05530135

Life-style Interventions for Modulating the Brain Phenotype of Takotsubo Cardiomyopathy

Life-Style Interventions for Modulating the Brain Phenotype of Takotsubo Cardiomyopathy - the BREAKOUT Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
85 (actual)
Sponsor
University of Aberdeen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Takotsubo cardiomyopathy presents like a heart attack and is typically triggered by intense emotional or physical stress. Recovery of this condition varies and many patients continue to suffer from symptoms such as fatigue and breathlessness for a protracted period after their event. The purpose of this study is to establish whether following a structured exercise program or a mental wellbeing program compared to usual care for 12 weeks after an episode of Takotsubo will result in significant improvement in the brain activity, general and mental wellbeing of patients.

Detailed description

Takotsubo cardiomyopathy is characterised by sudden onset left ventricular dysfunction precipitated by major stress. This neuro-cardiac condition has a 5-year morbidity and mortality comparable with acute myocardial infarction and no current therapies exist. The psycho-somatic basis of Takotsubo suggests that its neuro-biology could be amenable to modulation. Here, the investigators propose a mechanistic three-arm pilot feasibility trial of standardised physical exercise training, cognitive behavioural therapy and current standard of care in patients who suffered a very recent episode of takotsubo cardiomyopathy.

Conditions

Interventions

TypeNameDescription
OTHERExercise programExercise program
OTHERCognitive behavioural therapyCognitive behavioural therapy
OTHERStandard clinical careStandard clinical care

Timeline

Start date
2020-10-06
Primary completion
2023-08-31
Completion
2023-08-31
First posted
2022-09-07
Last updated
2023-12-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05530135. Inclusion in this directory is not an endorsement.